2003
DOI: 10.1176/appi.ajp.160.1.112
|View full text |Cite
|
Sign up to set email alerts
|

Obesity as a Correlate of Outcome in Patients With Bipolar I Disorder

Abstract: Obesity is correlated with a poorer outcome in patients with bipolar I disorder. Preventing and treating obesity in bipolar disorder patients could decrease the morbidity and mortality related to physical illness, enhance psychological well-being, and possibly improve the course of bipolar illness. Weight-control interventions specifically designed for patients with bipolar illness should be developed, tested, and integrated into the routine care provided for these patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

20
247
6
7

Year Published

2005
2005
2020
2020

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 365 publications
(280 citation statements)
references
References 23 publications
20
247
6
7
Order By: Relevance
“…In our sample, DSM-IV Axis III comorbidity was more prevalent amongst the most recurrent patients; in agreement with previous studies (Fagiolini et al 2002, Fagiolini et al 2003, it is possible to consider this finding as another risk factor of poorer functioning outcome amongst the bipolar patients.…”
Section: Discussionsupporting
confidence: 92%
“…In our sample, DSM-IV Axis III comorbidity was more prevalent amongst the most recurrent patients; in agreement with previous studies (Fagiolini et al 2002, Fagiolini et al 2003, it is possible to consider this finding as another risk factor of poorer functioning outcome amongst the bipolar patients.…”
Section: Discussionsupporting
confidence: 92%
“…Elevated rates of additional psychiatric comorbidity in patients with 2 versus 1 presenting disorder have been documented in a number of psychiatric populations (e.g., 20,21). Nevertheless, given that both obesity and anxiety comorbidity have been shown to correlate with indicators of poor prognosis in bipolar patients (e.g., delayed response to treatment, shorter time to recurrence) (22,23), future studies are needed to determine the impact of aberrant eating on the clinical course of bipolar disorder and its treatment. In addition, research to tease apart the temporal and pathophysiological relationships among eating disorder symptoms, obesity, mood disorder history, and other psychiatric co-morbidity seems warranted.…”
Section: Discussionmentioning
confidence: 99%
“…The serum levels of glucocorticoids and melatonin, factors with potent adipogenic properties, exhibit circadian oscillations (Hirota and Fukada 2004;Lowrey and Takahashi 2004). Eating during periods of darkness (Holmback et al 2002(Holmback et al , 2003Spiegel et al 2004) and antipsychotic drugs influencing circadian rhythms such as lithium chloride and valproic acid (Baptista et al 1995;Elmslie et al 2001;Atmaca et al 2002;Chengappa et al 2002;Fagiolini et al 2002Fagiolini et al , 2003Iwahana et al 2004) have been associated with an increased incidence of obesity. The serum levels of multiple adipose-derived proteins, including adiponectin, interleukin-6, leptin, lipoprotein lipase, PAI-1, and tumor necrosis factor-α, display a diurnal profile characterized by a distinct amplitude, zenith (peak), and nadir (trough) (Kotlar and Borensztajn 1977;Goubern and Portet 1981;Saad et al 1998;Ahmad et al 2001;Arasaradnam et al 2002;Mastronardi et al 2002;Gavrila et al 2003;Calvani et al 2004;Ruge et al 2004;Yildiz et al 2004).…”
Section: Introductionmentioning
confidence: 99%